Objective: This study aimed to investigate the effects of vaginal dilator use on female sexual function, self-compassion level, and quality of life in women undergoing brachytherapy for cervical cancer. Method: The study was conducted using a pre-test post-test quasi-experimental design. The study was conducted with 80 female patients between June 1, 2025, and February 1, 2026. Data were collected using the Patient Identification Form, Self-Compassion Scale-Short Form (SCS-SF), Female Sexual Function Scale (FSFI), and EORTC QLQ-C30. Participants were evaluated at three different time points (week 1, week 4, and week 12).
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Participant Information Form
Timeframe: baseline
Self-Compassion Scale-Short Form
Timeframe: first week
Self-Compassion Scale-Short Form
Timeframe: fourth week
Self-Compassion Scale-Short Form
Timeframe: twelfth week
Female Sexual Function Index
Timeframe: first week
Female Sexual Function Index
Timeframe: fourth week
Female Sexual Function Index
Timeframe: twelfth week
The EORTC QLQ-C30
Timeframe: first week
The EORTC QLQ-C30
Timeframe: fourth week
The EORTC QLQ-C30
Timeframe: twelfth week